Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
So most Pharma have a P38 inhibitor on the shelf but none of them work!!! Poolbeg are testing now to ascertain if theirs works
Iron - I think when its said Revenue is increasing it means more revenue from one year to the next - very simple really but you seem to be struggling
Bob - let’s just check your comments
Spin offs & divis - too early to dismiss
Rising costs - down from £21m to £16.5m
Tight margins - EBITDA margin increased from 9.5% to 12.8%
Can’t scale - last year grown 70% + this year 25%+
When you say Dyor - have you done any??
Hard to believe that sales will impress - also Ebita likely to be poor (lower end of range - or worse) and cash position looks like it will be potentially negative - can see these reacting badly on results day - I am short. The main problem is that they have set up the business (with all the cost structure) for revenues of £4billion and only trading at half that level - costs need urgent attention
As a CFO - do you expect to drive growth or just report on it??
Great results and Forward Looking Statements - cash up to £20m - how many times did Sikh /STT go on about this?? (Why aren’t they declaring cash balance / what are they hiding etc etc???)
It is a good question for Thursday. IMO I doubt whether Nat West (who are owed the £2m) would allow the Directors to sell assets on the cheap and then dump the Company (their legal agreements would have this covered) We could do with approaching Nat West to let them know that we have cash readily available to cover their loan if Seek defaults
I see it the other way around Moni - Seek have no money and a £2m loan due for repayment on 16th Sept (with a charge over all Seeks assets) - there is an opportunity to buy the 51% in Imutex that we don't have on the cheap. (unless they have recently found some additional funding)
Why would you sell as the share price recovery starts - isn’t that a classic Pi error
I read the Liberum report which clearly splits the Revenues £20m in the first half and £30m in the second - I doubt they would have made this up (as house Broker) they would have been give guidance by management (hope I'm wrong and H1 is better)
Yes I agree - more than 33p would be great (and according to CF perfectly possible) - don't see it short term as First Half results will be subdued - £20m Revenues and likely a lower cash balance. Second half should start to re rate the shares with sales around the £30m mark
Just read the Liberum note - very positive (I know they are Orph’s broker) looks like this year will be H2 weighted with £20m in the first half and £30m second half (and probably a lower cash balance until H2) it’s likely they will have been steered by management. Overall looking at circa 22p target price excluding spin offs (so probably nearer 30p all included)
‘Most investors’ - so nearly 670 million shares sold yesterday were there? (And the share price remained unchanged) you’re not short of being a clown
How does pointing out that a post is completely wrong constitute a ramp
No holding from anyone - other than CF who owns over 40 million - what a clown comment
That was for Karlo
And you recently bought in to Bens Creek at 45p (down over 10% already) which
- has no financial results
- strapped for cash
- debt on the balance sheet
- major shareholder dumped 100% of holding
- very opaque information flow
- market for its coal deteriorating
Snuffed itself out ?? When was that?!